Inflammatory Bowel Disease Education: I Can Hear the Extension for Community Healthcare Outcomes
نویسندگان
چکیده
T he rapid evolution of care for patients with inflammatory bowel disease (IBD) has resulted in significant variation in management of patients with IBD. Studies have identified disparities in management between experts in IBD and community providers. In addition, high volume IBD centers have improved operative and inpatient outcomes compared with hospitals that have lower volumes. In remote areas such as the Mountain West, the distances that must be traveled and snow fall in the winter create difficulties for patients to easily obtain care from referral centers with specific expertise such as IBD. It therefore seems reasonable that facilitating access to care for IBD patients to providers who are familiar with best practice guidelines will improve outcomes in patients with IBD. The IBD Live program developed by the regional academic centers and recently published by Regueiro et al in the IBD journal provides a valuable service to the participating IBD experts and their patients. Publishing the IBD Live case discussion provides case-based learning opportunity to disseminate information to a wider audience. Project ECHO (Extension for Community Healthcare Outcomes) was founded at the University of NewMexico by Dr. Sanjeev Arora so that primary care clinicians could treat hepatitis C in their own communities with support and guidance. This program has been shown to be a successful model for the management of hepatitis C. Project ECHO has now expanded to over 40 sites around the world. As the ECHO model expands, it is helping to address some of the most intractable problems of health care system, including inadequate or disparities in access to care, rising costs, systemic inefficiencies, and unequal or slow diffusion of best practices. Building on the hepatitis C Project ECHO model, in 2014, the University of Utah established the Mountain West IBD Knowledge Network (IBD ECHO) to provide IBD education, guidance, and coaching to the practicing gastroenterologists and other community providers such as physician assistants, nurse practitioners, surgeons, and some primary care physicians in remote and underserved areas across the Mountain West. Project ECHO is a collaborative model of medical education and care management and is not traditional telemedicine. The ECHO model does not directly “provide” care to patients. Instead, it dramatically increases access to specialty treatment in underserved areas by providing front-line clinicians with the knowledge and support they need to manage patients with complex conditions such as IBD. It does this by engaging clinicians in a continuous learning system and partnering them with specialists at an academic medical center or hub using videoconferencing technology. ECHO-based projects at the University of Utah reach out to 44 sites from 9 states (Utah, Wyoming, Montana, Idaho, Nevada, Colorado, Oregon, California, and Nebraska), and the IBD ECHO currently has participating sites from Utah, Nevada, Idaho, Montana, and Wyoming. Utah Project ECHO uses a mobile Polycom HDX 7000 Series videoconferencing unit to broadcast high-quality audiovisual sessions to providers that have logged into the HIPAA-compliant network bridge managed by the Utah Telehealth Network. The unit contains content-sharing capabilities, which makes it easy to display images, such as deidentified radiographic imaging and labs, PowerPoint presentations used during didactic sessions, and other updates/ guidelines. This multipoint videoconferencing system allows for face-to-face conversation between all participants. With a capacity for 50 participants in a single virtual clinic environment, the bridge provides an efficient mechanism for continuing education. Utah Telehealth Network works with the University of Utah ECHO program coordinator to set up, test, and certify videoconferencing connections for new participants. Most importantly, participation in the Utah IBD ECHO is at no cost to the participants, includes the secured videoconferencing software, and Category 1 continuing medical education credits. The participating providers need only to supply a computer with a microphone, camera, and internet access. The IBD ECHO sessions focus on case-based learning with cases presented by community providers, in addition to including brief didactic presentations by the IBD faculty devised to effectively educate providers on best practices and the practical application with guidance of a specialist. A typical IBD ECHO session begins with approximately 30 to 45 minutes of case presentations and discussion followed by a 10to 15-minute didactic presentation. The sessions are led by the University of Utah IBD faculty and a gastrointestinal/hepatology-focused clinical pharmacist. The gastrointestinal fellow on the IBD rotation is also in attendance. Before the session, community providers complete and submit deidentified case presentation forms that provide the necessary details required for the faculty to provide guidance, endoscopy reports, pathology reports, and imaging to the IBD ECHO coordinator, who prepares the case presentations for faculty review. The IBD faculty review the cases in advance to ensure that ECHO provider educational needs will be met, including the provision of clear recommendations. During the session, providers present cases and receive individualized mentorship and education regarding each case. Educational, collegial discussions occur during the case presentations. Providers may attend sessions for educational purposes, regardless of Received for publication February 11, 2015; Accepted March 10, 2015. The authors have no conflicts of interest to disclose. Copyright © 2015 Crohn’s & Colitis Foundation of America, Inc. DOI 10.1097/MIB.0000000000000432 Published online 4 May 2015.
منابع مشابه
Effect of Cyperus Rotundus on Cytokine Gene Expression in Experimental Inflammatory Bowel Disease
Background: The protective effect of the chloroform extract of Cyperus rotundus (CHCR) is attributed to its anti-inflammatory and antioxidant activities. Cytokines, important regulators of inflammation and repair, play a key role in the pathogenesis of inflammatory bowel disease (IBD). Targeting these cytokines can effectively ameliorate the symptoms of IBD. The aim of the present study was to ...
متن کاملApplication of extracellular vesicles in the treatment of inflammatory bowel disease
Introduction: Inflammatory bowel disease(IBD) is caused by genetic, environmental, microbial and immune factors. IBD has two primary forms: Ulcerative colitis and Crohn´s disease. The incidence of IBD has significantly increased over the last few decades. Given that patients have poor response to drug treatments or are resistant to drug therapies, new therapies are needed for gastrointestinal i...
متن کاملEvaluation of Bcl2/BAX genes expression ratio as a marker of inflammatory bowel disease
Background: Apoptosis is an essential physiological process to maintain immune homeostasis. T-cell incorrect apoptosis appears to be involved in chronic inflammatory diseases such as inflammatory bowel disease (IBD). The aim of this study was to evaluate the Bcl2/BAX genes expression ratio in patients with IBD (Crohn’s disease and ulcerative colitis) compared to healthy persons. Materials and M...
متن کاملThe Customer Quality of Delivered Care to Patients with Inflammatory Bowel Disease in Tabriz City, Iran, 2012
Abstract Background and purpose: Customer quality (CQ) refers to knowledge, attitude, and skills of service-user in treatment process and this study aims to assess it in delivered care to patients with inflammatory bowel disease (IBD) in Tabriz city, Iran, 2012. Materials and Methods: This is a cross-sectional investigation in which the target population includes 94 patients with IBD, who had m...
متن کاملThe Challenges of Living with Inflammatory Bowel Disease: Summary of a Summit on Patient and Healthcare Provider Perspectives
Canada has one of the highest rates of inflammatory bowel disease (IBD) and the disease represents a significant health, social, and economic burden. There is currently no cure for IBD, although earlier diagnosis and new therapies have improved the overall health outcomes and quality of life for patients. Crohn's and Colitis Canada is Canada's only national, volunteer-based charity dedicated to...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره 21 شماره
صفحات -
تاریخ انتشار 2015